Mabry Labs

Moe Chocolate Male Stud



Moe is a chocolate English male.

He will start breeding in 2019 and will be replacing Buster as Buster will be retiring soon.

We have listed the testing we added to him below. 

He is also tested for the diseases listed on our Genetic testing page.

He is our most extensively tested male to date. 


Moe was tested for the following diseases and we are happy to report he was clear on all of them.



  1. Coagulation factor VII deficiency
  2. Elliptocytosis
  3. Leukocyte adhesion deficiency, type III
  4. May-Hegglin anomaly
  5. P2RY12 receptor platelet disorder
  6. Prekallikrein deficiency
  7. Pyruvate kinase deficiency
  8. Von Willebrand disease
  9. Renal cystadenocarcinoma and nodular dermatofibrosis
  10. Amelogenesis imperfecta
  11. Multidrug resistance 1
  12. Cone degeneration
  13. Congenital stationary night blindness
  14. Dry eye curly coat syndrome
  15. Early retinal degeneration
  16. Hereditary cataracts
  17. Juvenile Laryngeal Paralysis and Polyneuropathy
  18. Multifocal retinopathy 1
  19. Multifocal retinopathy 2
  20. Multifocal retinopathy 3
  21. Primary lens luxation
  22. Primary open angle glaucoma
  23. Progressive retinal atrophy, Cone-rod dystrophy
  24. Progressive retinal atrophy
  25. Progressive rod-cone degeneration
  26. Progressive retinal atrophy Rod-cone dysplasia 3
  27. Progressive retinal atrophy, generalized
  28. Complement 3 deficiency
  29. Primary ciliary dyskinesia
  30. Trapped neutrophil syndrome
  31. Gallbladder mucoceles
  32. Glycogen storage disease IIIa
  33. Adult-onset neuronal ceroid lipofuscinosis
  34. Glycogen storage disease IIIa
  35. Glycogen storage disease Ia
  36. Glycogen storage disease VII
  37. Mucopolysaccharidosis I
  38. Neuronal ceroid lipofuscinosis 1
  39. Neuronal ceroid lipofuscinosis 10
  40. Neuronal ceroid lipofuscinosis 2
  41. Neuronal ceroid lipofuscinosis 4A
  42. Neuronal ceroid lipofuscinosis 5
  43. Neuronal ceroid lipofuscinosis 6
  44. Pompe disease
  45. Pyruvate dehydrogenase deficiency
  46. Pyruvate kinase deficiency
  47. Juvenile Laryngeal Paralysis and Polyneuropathy
  48. Adult-onset neuronal ceroid lipofuscinosis
  49. Congenital myasthenic syndrome
  50. Degenerative myelopathy
  51. Exercise-induced collapse
  52. Glycogen storage disease IIIa
  53. Juvenile Laryngeal Paralysis and Polyneuropathy
  54. Mucopolysaccharidosis I
  55. Musladin-Lueke syndrome
  56. Myotubular myopathy 1
  57. Osteochondrodysplasia
  58. Pompe disease
  59. Skeletal dysplasia 2
  60. Adult-onset neuronal ceroid lipofuscinosis
  61. Benign familial juvenile epilepsy
  62. Congenital myasthenic syndrome
  63. Degenerative myelopathy
  64. Episodic falling syndrome
  65. Exercise-induced collapse
  66. Juvenile Laryngeal Paralysis and Polyneuropathy
  67. Late onset ataxia
  68. Mucopolysaccharidosis I
  69. Musladin-Lueke syndrome
  70. Narcolepsy
  71. Neonatal cerebellar cortical degeneration
  72. Neonatal encephalopathy with seizures
  73. Neuronal ceroid lipofuscinosis 1
  74. Neuronal ceroid lipofuscinosis 10
  75. Neuronal ceroid lipofuscinosis 2
  76. Neuronal ceroid lipofuscinosis 4A
  77. Neuronal ceroid lipofuscinosis 5
  78. Neuronal ceroid lipofuscinosis 6
  79. Sensory ataxic neuropathy
  80. Spinocerebellar ataxia
  81. Startle disease
  82. Primary ciliary dyskinesia
  83. Primary ciliary dyskinesia
  84. Anhidrotic ectodermal dysplasia
  85. Dry eye curly coat syndrome
  86. Dystrophic epidermolysis bullosa
  87. Ectodermal dysplasia
  88. Epidermolytic hyperkeratosis
  89. Hereditary nasal parakeratosis
  90. Renal cystadenocarcinoma and nodular dermatofibrosis
  91. Fanconi syndrome
  92. Hyperuricosuria
  93. Persistent Müllerian duct syndrome
  94. Primary ciliary dyskinesia
  95. Primary hyperoxaluria
  96. Renal cystadenocarcinoma and nodular dermatofibrosis